Antibiotic Resistance of 434 Strains of Pseudomonas aeruginosa
Xing Zhong
Abstract
Xing Zhong
Abstract
OBJECTIVE To study the drug sensitivity and drug resistance of Pseudomonas aeruginosa to 38 commonly used antibiotics. METHODS To collect data of the 434 strains of bacteria separated from clinical specimen from Jan 1998 to Feb 2002 and make analyses on the drug sensitivity test. RESULTS The average drug sensitivity rate of P. aeruginosa to 38 commonly used antibiotics is 37.59%, average drug resistance rate is 62.41%. The drug resistant strains to more than triple drugs account for 78.57%. The sensitivity rate of cefoperazone/sulbactam is the highest (87.50%), the others in order are amikacin (86.27%) and imipenem(84.69%). CONCLUSIONS P. aeruginosa is one of the common pathogens in clinics. The problem of drug resistance is very prominent. With the patient infected by P. aeruginosa, it should be first treated experiencely by cefoperazone/sulbactam, amikacin and imipenem, et al.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To study the drug sensitivity and drug resistance of Pseudomonas aeruginosa to 38 commonly used antibiotics. METHODS To collect data of the 434 strains of bacteria separated from clinical specimen from Jan 1998 to Feb 2002 and make analyses on the drug sensitivity test. RESULTS The average drug sensitivity rate of P. aeruginosa to 38 commonly used antibiotics is 37.59%, average drug resistance rate is 62.41%. The drug resistant strains to more than triple drugs account for 78.57%. The sensitivity rate of cefoperazone/sulbactam is the highest (87.50%), the others in order are amikacin (86.27%) and imipenem(84.69%). CONCLUSIONS P. aeruginosa is one of the common pathogens in clinics. The problem of drug resistance is very prominent. With the patient infected by P. aeruginosa, it should be first treated experiencely by cefoperazone/sulbactam, amikacin and imipenem, et al.
Key concepts: Cefoperazone, Sulbactam, Amikacin, Imipenem, Pseudomonas aeruginosa, Drug resistance, Microbiology, Antibiotics